Pipeline -Pipeline -PipelineIn the current situation on this message board, the differing viewpoints are clear and evident.
For example, Boazklin... describes the situation in the past and present, and expresses disappointment that absolutely nothing has happened so far with regard to our pipeline. Right!!! - and this is also reflected in our disappointing share price.
Proph.. can use as many biotech stocks or indices as a comparison - the fact is: Probably almost no one on this message board has made money with Ceapro stock to date.
On the other hand, our permanent optimist Proph... does not respond to the criticism of the development so far, but prefers to focus on the future - the pipeline.
This consists of Ceapro's (hopefully positive) future. There you can always list the same names (Miller, Ask etc.), the competitor companies that are highly valued with a similar pipeline etc. We at the message board always ask ourselves the same questions:
If everything is so positive, why doesn't the stock market value Ceapro accordingly? Are funds, analysts or shareholders just stupid? - and only proph... sees the situation correctly?
Just a few weeks ago, Proph... dismissed the 3rd quarter figures by saying that individual quarters do not represent a discussion point for a whole year. When I then pointed out that the figures for the 4th quarter were also weaker than in the previous year, his argument was that there was still growth for the year as a whole. Only after I insisted again and expressed my expectations regarding a probably weaker 1st quarter, now suddenly concessions come which are garnished with the hope!!! for an increase in the full year 2023 (see Symrise).
How times change!
The shareholders should express their dissatisfaction with a clear vote at the Annual General Meeting.